Don Stablein

2.4k total citations
12 papers, 957 citations indexed

About

Don Stablein is a scholar working on Transplantation, Nephrology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Don Stablein has authored 12 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Transplantation, 4 papers in Nephrology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Don Stablein's work include Renal Transplantation Outcomes and Treatments (7 papers), Renal Diseases and Glomerulopathies (3 papers) and HIV Research and Treatment (2 papers). Don Stablein is often cited by papers focused on Renal Transplantation Outcomes and Treatments (7 papers), Renal Diseases and Glomerulopathies (3 papers) and HIV Research and Treatment (2 papers). Don Stablein collaborates with scholars based in United States, Australia and Ireland. Don Stablein's co-authors include Stanley C. Jordan, Dolly B. Tyan, Matthew J. McIntosh, Ashley Vo, Connie L. Davis, Ralph J. Graff, Dawn S. Milliner, Ron Shapiro, Mieko Toyoda and Deborah Adey and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Journal of Allergy and Clinical Immunology.

In The Last Decade

Don Stablein

12 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Don Stablein United States 10 437 269 259 225 176 12 957
Karine Hadaya Switzerland 20 394 0.9× 330 1.2× 322 1.2× 304 1.4× 138 0.8× 68 1.5k
Marie Matignon France 20 528 1.2× 257 1.0× 206 0.8× 165 0.7× 188 1.1× 62 965
A Duboust France 14 359 0.8× 259 1.0× 160 0.6× 142 0.6× 141 0.8× 45 763
Vinita Sehgal United States 14 609 1.4× 363 1.3× 203 0.8× 138 0.6× 78 0.4× 20 897
Nasimul Ahsan United States 20 819 1.9× 615 2.3× 92 0.4× 144 0.6× 280 1.6× 39 1.5k
Mark Hathaway United Kingdom 18 300 0.7× 326 1.2× 178 0.7× 73 0.3× 140 0.8× 38 924
William R. Mulley Australia 17 345 0.8× 260 1.0× 188 0.7× 118 0.5× 101 0.6× 67 891
Johan Noble France 16 340 0.8× 171 0.6× 129 0.5× 109 0.5× 69 0.4× 78 641
M. F. Gagnadoux France 16 126 0.3× 159 0.6× 84 0.3× 185 0.8× 91 0.5× 41 931
Anna Manonelles Spain 16 400 0.9× 241 0.9× 167 0.6× 227 1.0× 88 0.5× 52 974

Countries citing papers authored by Don Stablein

Since Specialization
Citations

This map shows the geographic impact of Don Stablein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Stablein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Stablein more than expected).

Fields of papers citing papers by Don Stablein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don Stablein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Stablein. The network helps show where Don Stablein may publish in the future.

Co-authorship network of co-authors of Don Stablein

This figure shows the co-authorship network connecting the top 25 collaborators of Don Stablein. A scholar is included among the top collaborators of Don Stablein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Don Stablein. Don Stablein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lee, Joshua D., Edward V. Nunes, Patricia Novo, et al.. (2016). NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale. Contemporary Clinical Trials. 50. 253–264. 49 indexed citations
2.
Wright, Benjamin L., Michael D. Kulis, Kelly Orgel, et al.. (2015). Egg-Specific IgA and IgA2 Are Associated with Sustained Unresponsiveness to Egg Following Oral Immunotherapy. Journal of Allergy and Clinical Immunology. 135(2). AB38–AB38. 1 indexed citations
3.
Mooney, Larissa J., Suzanne Nielsen, Andrew J. Saxon, et al.. (2012). Cocaine Use Reduction with Buprenorphine (CURB): Rationale, design, and methodology. Contemporary Clinical Trials. 34(2). 196–204. 15 indexed citations
4.
Robb, Merlin L., Supachai Rerks‐Ngarm, Sorachai Nitayaphan, et al.. (2012). Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144. The Lancet Infectious Diseases. 12(7). 531–537. 127 indexed citations
5.
Nguyen, Stéphanie, Karen Martz, Don Stablein, & Alicia M. Neu. (2011). Wait list status of pediatric dialysis patients in North America. Pediatric Transplantation. 15(4). 376–383. 17 indexed citations
6.
Graham, Barney S., M. Juliana McElrath, Michael C. Keefer, et al.. (2010). Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity. PLoS ONE. 5(8). e11995–e11995. 56 indexed citations
7.
Braun, Michael, Don Stablein, Lorraine Hamiwka, et al.. (2005). Recurrence of Membranoproliferative Glomerulonephritis Type II in Renal Allografts. Journal of the American Society of Nephrology. 16(7). 2225–2233. 69 indexed citations
8.
Jordan, Stanley C., Dolly B. Tyan, Don Stablein, et al.. (2004). Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal Disease. Journal of the American Society of Nephrology. 15(12). 3256–3262. 329 indexed citations
9.
Reddy, Kunam S., Don Stablein, Sarah Taranto, et al.. (2003). Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. American Journal of Kidney Diseases. 41(2). 464–470. 153 indexed citations
10.
Weisdorf, Daniel J., David D. Hurd, Shelly Carter, et al.. (2003). Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review. Biology of Blood and Marrow Transplantation. 9(8). 512–518. 48 indexed citations
11.
12.
Furth, Susan L., Don Stablein, Richard Ν. Fine, Neil R. Powe, & Barbara A. Fivush. (2002). Adverse Clinical Outcomes Associated With Short Stature at Dialysis Initiation: A Report of the North American Pediatric Renal Transplant Cooperative Study. PEDIATRICS. 109(5). 909–913. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026